<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/945A3623-B877-47A7-AE57-2EAA4B75E199"><gtr:id>945A3623-B877-47A7-AE57-2EAA4B75E199</gtr:id><gtr:name>NHS Scotland</gtr:name><gtr:address><gtr:line1>Property and Environment Forum</gtr:line1><gtr:line2>4th Floor St Andrew</gtr:line2><gtr:line3>141 West Nile Street</gtr:line3><gtr:postCode>G1 2RN</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FDDFAB1D-A00A-4BDE-BB41-754B39324625"><gtr:id>FDDFAB1D-A00A-4BDE-BB41-754B39324625</gtr:id><gtr:name>Leo Foundation</gtr:name><gtr:address><gtr:line1>55 Industriparken</gtr:line1><gtr:postCode>DK-2750</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D35F3544-BE4C-432D-9A90-D8E58B4A2023"><gtr:id>D35F3544-BE4C-432D-9A90-D8E58B4A2023</gtr:id><gtr:name>Selcia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CB04479F-D12C-4FF3-9E3C-C32EE03564A0"><gtr:id>CB04479F-D12C-4FF3-9E3C-C32EE03564A0</gtr:id><gtr:name>BK Medical</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5786934C-E914-4DBB-B39D-6D5A4B56DA13"><gtr:id>5786934C-E914-4DBB-B39D-6D5A4B56DA13</gtr:id><gtr:name>Lamellar Biomedical Ltd</gtr:name><gtr:address><gtr:line1>Caledonian House</gtr:line1><gtr:line2>Phoenix Crescent</gtr:line2><gtr:line3>Strathclyde Business Park, Bellshill</gtr:line3><gtr:postCode>ML4 3NJ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AC164095-49BC-4450-8225-CC32DB237D60"><gtr:id>AC164095-49BC-4450-8225-CC32DB237D60</gtr:id><gtr:name>Asymptote</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/945A3623-B877-47A7-AE57-2EAA4B75E199"><gtr:id>945A3623-B877-47A7-AE57-2EAA4B75E199</gtr:id><gtr:name>NHS Scotland</gtr:name><gtr:address><gtr:line1>Property and Environment Forum</gtr:line1><gtr:line2>4th Floor St Andrew</gtr:line2><gtr:line3>141 West Nile Street</gtr:line3><gtr:postCode>G1 2RN</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FDDFAB1D-A00A-4BDE-BB41-754B39324625"><gtr:id>FDDFAB1D-A00A-4BDE-BB41-754B39324625</gtr:id><gtr:name>Leo Foundation</gtr:name><gtr:address><gtr:line1>55 Industriparken</gtr:line1><gtr:postCode>DK-2750</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D35F3544-BE4C-432D-9A90-D8E58B4A2023"><gtr:id>D35F3544-BE4C-432D-9A90-D8E58B4A2023</gtr:id><gtr:name>Selcia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CB04479F-D12C-4FF3-9E3C-C32EE03564A0"><gtr:id>CB04479F-D12C-4FF3-9E3C-C32EE03564A0</gtr:id><gtr:name>BK Medical</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5786934C-E914-4DBB-B39D-6D5A4B56DA13"><gtr:id>5786934C-E914-4DBB-B39D-6D5A4B56DA13</gtr:id><gtr:name>Lamellar Biomedical Ltd</gtr:name><gtr:address><gtr:line1>Caledonian House</gtr:line1><gtr:line2>Phoenix Crescent</gtr:line2><gtr:line3>Strathclyde Business Park, Bellshill</gtr:line3><gtr:postCode>ML4 3NJ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AC164095-49BC-4450-8225-CC32DB237D60"><gtr:id>AC164095-49BC-4450-8225-CC32DB237D60</gtr:id><gtr:name>Asymptote</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/43624727-2D66-49AE-8923-426DD4CDD141"><gtr:id>43624727-2D66-49AE-8923-426DD4CDD141</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:surname>Seckl</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_15027"><gtr:id>0FC7ADF1-109C-43E3-A486-E490B3C5E0A0</gtr:id><gtr:title>Edinburgh Medical Technology Acceleration to Exit EMTATE</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_15027</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The Confidence in Concept scheme is a key part of MRC?s translational research strategy and provides annual awards to institutions, to be used flexibly to support the earliest stages of multiple translational research projects. The award can be used by the institution to support a number of preliminary-stage translational projects. The projects supported should aim to provide sufficient preliminary data to establish the viability of an approach ?? before seeking more substantive funding.&amp;nbsp; It is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work or feasibility studies to establish the viability of an approach.</gtr:technicalSummary><gtr:fund><gtr:end>2018-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>900000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lamellar Biomedical Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Radiation induced damage CiC3</gtr:description><gtr:id>D03F76F6-AF3A-49A2-81E8-41D21FC8B834</gtr:id><gtr:impact>positive data obtained</gtr:impact><gtr:outcomeId>58c6d9aae8c694.44950279-1</gtr:outcomeId><gtr:partnerContribution>Lamellasomes as potential protectant</gtr:partnerContribution><gtr:piContribution>model for radiation damage in sheep</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>BK Medical</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>Super resolution ultrasound CiC3</gtr:description><gtr:id>CD43EFD9-5867-470A-8CE6-914346EC41E3</gtr:id><gtr:impact>positive data and a patent</gtr:impact><gtr:outcomeId>58c6db0b104f22.65711278-1</gtr:outcomeId><gtr:partnerContribution>BK are providing the machine</gtr:partnerContribution><gtr:piContribution>we are providing the research subjects</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Strathclyde</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CiC 2014 (crryopreserved hESC)</gtr:description><gtr:id>005C88E4-EF48-4741-AC08-8121BB551118</gtr:id><gtr:impact>Enhanced existing collaboration with Dr Michele Zagnoni (University of Strathclyde). On 29th February, we submitted a full proposal to the Wellcome Trust for a Biomedical Resource and Technology grant, which plans to use technology obtained during this MRC CiC project.</gtr:impact><gtr:outcomeId>56df21d3a30058.74392763-1</gtr:outcomeId><gtr:partnerContribution>Stabilisation technology</gtr:partnerContribution><gtr:piContribution>stem Cells</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CiC 2014 (cryopreserved hESC)</gtr:description><gtr:id>39656C29-B484-4BFF-800B-BFAE5249787F</gtr:id><gtr:impact>This is a direct application of the know-how gained from this MRC CiC project.</gtr:impact><gtr:outcomeId>56df225758cfb9.92169565-1</gtr:outcomeId><gtr:partnerContribution>transplantation into immune-compromised rats</gtr:partnerContribution><gtr:piContribution>New collaboration with Dr Mariah Lelos (Cardiff University). In December, 2015 we transported cryopreserved midbrain dopaminergic (mDA) precursors to Dr Lelos' lab for transplantation into immune-compromised rats.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CiC 2014 (ultrasound guidance)</gtr:description><gtr:id>28E626DB-9DB9-4BF1-9279-3594E25E88EB</gtr:id><gtr:impact>The two applicants (Fiona Denison and Marc Desmulliez) did put together multi-lateral partnership with the following people:
1) Prof. Graeme Maccleod, from NHS Tayside and Ninewells Hospital. Graeme is an anaesthetist.
2) Prof. Alistair Milne, from NHS Lothian. Alistair is an anaesthetist.
3) Prof. Christine Demore, from the University of Glasgow. Christine is an expert in ultrasound arrays. Rachel MacPhillips, Christine's PhD student, spent about two weeks working with my staff on the bonding technology for the epidural needle. 
4) Dr. Holly Lay, from the University of Glasgow. Holly is a Research Associate specialised in image processing of ultrasound images.</gtr:impact><gtr:outcomeId>56df2bbed30c21.91905761-1</gtr:outcomeId><gtr:partnerContribution>multiple expertise in surgery and engineering</gtr:partnerContribution><gtr:piContribution>medical concept and engineering</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Asymptote</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>cic 2014 (cryopreserved hESC)</gtr:description><gtr:id>D5340294-E460-4844-8B32-065500B969F2</gtr:id><gtr:impact>new improved methods</gtr:impact><gtr:outcomeId>56df21230f8d26.05212066-1</gtr:outcomeId><gtr:partnerContribution>Asymptote controlled-rate freezers for cryopreserving cells for clinical application</gtr:partnerContribution><gtr:piContribution>stem cells</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Selcia</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CiC 2014 (anti-bacterial)</gtr:description><gtr:id>ECAEAD3F-0742-46E1-9A48-8D0B6C962377</gtr:id><gtr:impact>As a result of our preliminary work on developing assays to test for small molecule inhibitors of the glycolytic pathway we have been awarded two grants to develop High Throughput Screens for testing by the European Lead Factory: project ref: &amp;quot;ADF15-0087&amp;quot; entitled: &amp;quot;bacterial PFK inhibition&amp;quot; and project ref: &amp;quot;ADF15-0089&amp;quot; entitled: &amp;quot;FBA as an antibacterial target &amp;quot; have both been accepted for screening by the ELF review panel.</gtr:impact><gtr:outcomeId>56df2963683885.12656712-1</gtr:outcomeId><gtr:partnerContribution>medicinal chemistry</gtr:partnerContribution><gtr:piContribution>structure based drug design</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NHS Scotland</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CiC2014 (tablet for AD diagnosis)</gtr:description><gtr:id>925EE207-D901-41EC-9327-6FC1FE155AAE</gtr:id><gtr:impact>To further increase the rate of recruitment of patients with mild Alzheimer's disease we have then widened our recruitment area beyond Stirling to include two consultants at the Community Hospital in Falkirk: Drs Debbie Browne and Parvez Thekkumpurath have agreed to refer patients with mild Alzheimer's disease to our study. The study has also been added to the Join Dementia Research (JDR) register, which is a national register of over 14,000 patients and healthy individuals interested in taking part in dementia research. This service allows prospective participants, who meet eligibility criteria for a study, to express interest in taking part and provides researchers with the contact details of interested patients. This will increase the rate of recruitment for both the current study and future work.</gtr:impact><gtr:outcomeId>56df286a98d420.08412096-1</gtr:outcomeId><gtr:partnerContribution>To further increase the rate of recruitment of patients with mild Alzheimer's disease</gtr:partnerContribution><gtr:piContribution>Tablet AD for detection</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>LEO Foundation</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>Identification of drugs for atopic dermatitis</gtr:description><gtr:id>4BB63794-2816-4527-831A-5751E83709C2</gtr:id><gtr:impact>new potential agents</gtr:impact><gtr:outcomeId>58c6dba9833f05.69408940-1</gtr:outcomeId><gtr:partnerContribution>research models</gtr:partnerContribution><gtr:piContribution>selection of agents</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Selcia</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>anti bacerials CiC 3</gtr:description><gtr:id>9AF34D6C-87EE-4DAC-9D9E-9315D33965F2</gtr:id><gtr:impact>novel compounds</gtr:impact><gtr:outcomeId>58c6d798f06f21.39477939-1</gtr:outcomeId><gtr:partnerContribution>selcia are providing medicinal chemistry</gtr:partnerContribution><gtr:piContribution>we are providing biology</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CiC2014 (cryopreserved hESC)</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>UCB Pharma</gtr:fundingOrg><gtr:id>00FE0186-A967-4027-94D6-635096EEAFAB</gtr:id><gtr:outcomeId>56df23279c3832.19783021</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1350000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CiC 2014 Tablet application for AD</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>Economic and Social Research Council</gtr:fundingOrg><gtr:fundingRef>ES/N010728/1</gtr:fundingRef><gtr:id>06D5541D-4D54-44FC-A724-6588C76A9C48</gtr:id><gtr:outcomeId>56df278391e051.17954540</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>Indonesia, Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CiC 2014 (magnetosome)</gtr:description><gtr:end>2019-10-02</gtr:end><gtr:fundingOrg>National Research Council of Republic Indonesia (DRN)</gtr:fundingOrg><gtr:id>3D7AD3C7-B583-4BD0-B4B8-2644DBC939E9</gtr:id><gtr:outcomeId>56df24769d2931.40975832</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CiC 2014 (cryopreservation hESC)</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>Cure Parkinson's Trust</gtr:fundingOrg><gtr:id>B85E5B3D-A2DA-4B9D-8045-2B6638EE2546</gtr:id><gtr:outcomeId>56df239cc85ad8.02281598</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CiC 2014 (Point of care miRNA)</gtr:description><gtr:end>2020-10-02</gtr:end><gtr:fundingOrg>Axis-Shield</gtr:fundingOrg><gtr:id>E488F58E-D66D-494E-88D7-930AF07312AE</gtr:id><gtr:outcomeId>56df1f89e3beb9.00333353</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2017-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>microfluidic device comprising a plurality of layers and a common manifold, wherein a fluid comprising a target population of particles having a specified range of diameters may be processed by the device by flowing from the common manifold through the channels of each layer within the plurality of layers, and fluid collected from a first outlet of each layer within the plurality of layers comprises the target population of particles, and fluid collected from a second outlet of each layer within the plurality of layers is substantially devoid of the target population of particles. A method of use of said device and systems comprising at least one said device are also presented.microfluidics system</gtr:description><gtr:grantRef>MC_PC_15027</gtr:grantRef><gtr:id>7B6EE980-147C-4766-A282-265D7FAEC5FE</gtr:id><gtr:impact>supporting project</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>56df0cb6059941.42366998</gtr:outcomeId><gtr:patentId>PCT/GB2016/051713</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>microfluidics system</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>A biosensor comprising a swellable biologically sensitive element comprising a nucleic acid probe and a physicoelectrical transducer associated with the swellable biologically sensitive element. The physicoelectrical transducer converts the swelling of the swellable biologically sensitive element into a detectable electrical property. In preferred embodiments the biosensor comprises an oligonucleotide cross-linked polymer composite mounted on a suitable substrate comprising electrodes adapted to measure electrical impedance. Associated methods and devices comprising said biosensor are also provided.</gtr:description><gtr:grantRef>MC_PC_15027</gtr:grantRef><gtr:id>E068C8BB-B7E8-47E5-9DD2-FE4383085F32</gtr:id><gtr:impact>novel assay system</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>56df0c4854e974.81333021</gtr:outcomeId><gtr:patentId>Patent Application No 1511969.6,</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>assay</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Prediction of response to endocrine therapy AHS. Filed 09/12/2014. This application is directed to the original four gene test and also covers the redefined 2-gene version of the test that has been developed since initial filing and publication
In one embodiment, step (ii) of the first aspect of the invention comprises determining in the first sample the expression level of only the IL6ST gene. 
In one embodiment, step (ii) of the first aspect of the invention further comprises determining in the first sample the expression level of the NGFRAP1 gene. The NGFRAP1 gene encodes the BEX3 protein (Winter EE et al. BMC Evol. Biol. 2005 ;5:54 PMID: 16221301 ). BEX3 is a p75NTR-associated protein that mediates apoptosis in response to Nerve Growth Factor by interacting with the intracellular death domain of P75-NTR (Mukai J et al. J. Biol. Chem. 2000 Jun;275(23): 17566-17570 PMID: 10764727). Besides a small number of studies validating the interaction of BEX3 and p75-NTR in vivo, very little is known about the interaction of these proteins (Rapp G et al. DNA Cell Biol. 1990 Sep;9(7):479-485 PMID: 2171551 ). 
Preferably, step (ii) of the first aspect of the invention further comprises determining in the first sample the expression level of the LAX1 gene and/or HPRT1 gene.</gtr:description><gtr:grantRef>MC_PC_15027</gtr:grantRef><gtr:id>B136541A-A844-4E05-B238-44E1C21CB847</gtr:id><gtr:impact>Establishing basis for further collaborations</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58c9aad160e741.69607212</gtr:outcomeId><gtr:patentId>WO2016092299</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Methods and kits for predicting the response to therapy of cancer</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E58DEBEB-65A8-4C19-8A6F-04544D7A42B1</gtr:id><gtr:title>Anti-embolism stockings, the similarities and differences</gtr:title><gtr:parentPublicationTitle>The Journal of The Textile Institute</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ba941afcef5ea52bbc7627fad5c912a"><gtr:id>2ba941afcef5ea52bbc7627fad5c912a</gtr:id><gtr:otherNames>Rae M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a79d3206c3661.48101738</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>945F3998-B4CA-4ED4-BD11-B6316F29FF41</gtr:id><gtr:title>Histology-based homogenization analysis of soft tissue: application to prostate cancer.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea0af649bb629d35a080ab9251c35350"><gtr:id>ea0af649bb629d35a080ab9251c35350</gtr:id><gtr:otherNames>Palacio-Torralba J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn><gtr:outcomeId>5a79d40acbb7a8.26811531</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15027</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C4255A20-7C03-4147-BA26-8D72C9457F1C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Health Uncodeable</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>06E85C67-BEDD-4C93-990D-B74FCF876924</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Research Uncodeable</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>